Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report) shares gapped down before the market opened on Thursday . The stock had previously closed at $0.6959, but opened at $0.6331. Sino Biopharmaceutical shares last traded at $0.6331, with a volume of 1,000 shares changing hands.
Sino Biopharmaceutical Trading Down 8.6%
The company has a 50-day moving average price of $0.75 and a two-hundred day moving average price of $0.82.
Sino Biopharmaceutical Company Profile
Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.
The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.
See Also
- Five stocks we like better than Sino Biopharmaceutical
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
- IREN Is Flipping the Switch from Bitcoin to AI
- This Quantum Computing Stock May Be Closer to a Breakout Than You Think
- RTX Is Set to Revolutionize Munitions Manufacturing
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
